Mar 21, 07
|
| NEW STORY |
| 05:08 ET |
Merck Initiates Squeeze Out Procedure for Shares of Merck Serono S.A.
|
|
| NEW STORY |
| 02:15 ET |
Merck Serono Confirms Previously Announced 2006 Figures
|
|
Mar 01, 07
|
| 01:15 ET |
Merck KGaA Announces Serono Preliminary Figures for 2006
|
|
Jan 30, 07
|
| 01:15 ET |
Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device
|
|
Jan 24, 07
|
| 01:15 ET |
Merck Serono Has Initiated the ONWARD Study to Evaluate Oral Cladribine as Add-on Treatment for Multiple Sclerosis
|
|
Jan 16, 07
|
| 09:30 ET |
Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria
|
|
| 01:15 ET |
Merck Serono Completes Patient Enrollment in CLARITY Phase III Pivotal Clinical Trial of Oral Cladribine
|
|
Jan 08, 07
|
| 01:15 ET |
Merck Serono is Launched
|
|
Jan 05, 07
|
| 16:46 ET |
Merck KGaA Acquires Majority Shareholding in Serono S.A.
|
|
Dec 20, 06
|
| 01:00 ET |
ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept in Rheumatoid Arthritis
|
|
Dec 12, 06
|
| 01:00 ET |
Serono Announces Initiation of the Reflex Trial to Evaluate New Formulation of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
|
|
Nov 13, 06
|
| 01:00 ET |
ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus
|
|
Oct 19, 06
|
| 01:00 ET |
Serono Delivers Strong Adjusted* Net Income of $183.5m in Third Quarter 2006
|
|
Oct 16, 06
|
| 01:00 ET |
Serono and Newron Announce Global Development and Commercialization Agreement for Safinamide
|
|
Oct 02, 06
|
| 01:00 ET |
Final Data From Two Phase II Trials Indicate Activity of Adecatumumab (MT201) in Breast and Prostate Cancer
|
|
Sep 28, 06
|
| 01:00 ET |
One-year Data From Phase III Trial Show That New Formulation of Rebif(r) Offers Substantial Improvement in Tolerability and Immunogenicity Profiles
|
|
Sep 25, 06
|
| 16:01 ET |
Serono: Publication of Interests (Art. 21 LBVM [Swiss Stock Market Law])
|
|
| 10:00 ET |
Study Shows Patient Preference for Gonal-f(R) RFF Pen to Treat Infertility
|
|
Sep 21, 06
|
| 08:41 ET |
Merck KgaA to Acquire Serono
|
|
| 01:00 ET |
Serono's Oral Cladribine for the Treatment of Multiple Sclerosis Awarded Fast Track Status by FDA
|
|
Sep 18, 06
|
| 01:00 ET |
Serono and Syntonix to Pursue the Development of a Long-Acting, Inhaleable FSH Therapy to Treat Infertility
|
|
Sep 12, 06
|
| 07:00 ET |
BioMarin and Serono Announce Data on Phenoptin in PKU to be Presented at the 56th Annual Meeting of the American Society of Human Genetics
|
|
Aug 17, 06
|
| 16:05 ET |
Serono Announces Results From Pivotal Phase III Clinical Trial of Its Proprietary Recombinant Human Growth Hormone in the Treatment of HARS at the XVI International AIDS Conference
|
|
Jul 26, 06
|
| 16:01 ET |
Serono Delivers Second Quarter EPS of $12.92, Up 25.2% on Adjusted(1) Basis
|
|
Jul 10, 06
|
| 01:00 ET |
European Commission Approves Revision of Therapeutic Indication for Rebif(R)
|
|
Jun 26, 06
|
| 01:00 ET |
Zymogenetics and Serono Present Positive Results of TACI-Ig Phase 1b Trial in Rheumatoid Arthritis at Eular Meeting
|
|
May 09, 06
|
| 01:03 ET |
Serono Announces New Appointments to its Executive Management Board
|
|
Apr 25, 06
|
| 10:23 ET |
Serono Shareholders Approve Resolutions at Annual General Meeting
|
|
Apr 20, 06
|
| 01:02 ET |
Serono Delivers Strong First Quarter 2006 With Revenue Growth of 16.4% in Local Currencies
|
|
Apr 10, 06
|
| 01:02 ET |
Serono Announces Termination of Discussions Concerning a Sale of the Company
|
|
Apr 04, 06
|
| 01:02 ET |
Serono Submits New Formulation of Rebif(R) for Approval in the United States and in Europe
|
|
Mar 31, 06
|
| 00:02 ET |
Serono's Board of Directors to Propose an Increase in Authorized Share Capital to the Forthcoming Annual Shareholders' Meeting to Provide the Company With Financing Capacity
|
|
Mar 15, 06
|
| 16:04 ET |
BioMarin and Serono Announce Positive Results From Phase 3 Clinical Study of Phenoptin for PKU
|
|
Feb 06, 06
|
| 01:51 ET |
Serono's 2005 Adjusted(i) EPS Increased by 34.6%
|
|
| 01:02 ET |
Seronons 2005 Adjusted(i) EPS Increased by 34.6%
|
|
Jan 24, 06
|
| 01:02 ET |
Serono's Gonal-f(R) Approved in Japan for the Treatment of Male Hypogonadotropic Hypogonadism
|
|
Jan 09, 06
|
| 01:01 ET |
Serono Completes Second Phase III Trial of its Proprietary Recombinant Human Growth Hormone for HIV-Associated Adipose Redistribution Syndrome (HARS)
|
|
Dec 15, 05
|
| 13:19 ET |
Serono Announces Formal Conclusion of Serostim Settlement
|
|
Nov 09, 05
|
| 02:01 ET |
Immune Response to Influenza Vaccine is Maintained in MS Patients Treated With Rebif(R)
|
|
Nov 08, 05
|
| 07:09 ET |
Goldman Sachs Retained to Explore Strategic Alternatives
|
|
Nov 03, 05
|
| 08:01 ET |
Brooke Shields Lends Her Support to Encourage Women to Take Action Early if They Have Trouble Conceiving
|
|
Oct 25, 05
|
| 01:01 ET |
Serono and Rigel Sign Agreement to Develop and Commercialize Aurora Kinase Inhibitors
|
|
| 01:00 ET |
Serono's Third Quarter 2005 Adjusted EPS Increased by 37.6%
|
|
Oct 17, 05
|
| 11:40 ET |
Serono Announces Final Settlement of Serostim(R) Investigation
|
|
| 08:04 ET |
Serono Announces Significant Advances in Identifying Most Viable Embryos for Transfer During IVF Procedures
|
|
Oct 03, 05
|
| 17:30 ET |
Serono: Data And Safety Monitoring Board Recommends Discontinuation of Canvaxin(TM) Phase 3 Clinical Trial for Patients With Stage III Melanoma
|
|
Aug 18, 05
|
| 01:00 ET |
Serono and Genmab Announce Global Development and Commercialization Agreement for Humax-CD4
|
|
Aug 10, 05
|
| 08:31 ET |
Fertility LifeLines(TM) Offers Single Destination for Access to Infertility Information, Support and Savings
|
|
Jul 19, 05
|
| 16:04 ET |
Serono Delivers Strong Second Quarter Results
|
|
Jul 13, 05
|
| 02:54 ET |
Serono Welcomes Positive Ratings From Credit Agencies
|
|
May 17, 05
|
| 01:00 ET |
Serono and NovImmune to Collaborate in Development of Two Novel Treatments for Autoimmune Diseases
|
|
May 16, 05
|
| 00:30 ET |
BioMarin And Serono Form Strategic ALLIANCE for the Development and Commercialization of Phenoptin(TM) and Phenylase(TM)
|
|
Apr 26, 05
|
| 11:01 ET |
Serono Shareholders Approve Resolutions at Annual General Meeting
|
|
Apr 06, 05
|
| 01:00 ET |
Serono Announces Discontinuation of Onercept in Moderate-to-Severe Psoriasis and Canvaxin(TM) in Stage IV Melanoma
|
|
Mar 31, 05
|
| 00:00 ET |
Serono and Syntonix Sign Worldwide Agreement to Develop and Commercialize an Inhaleable Interferon-Beta Therapy for Multiple Sclerosis
|
|
Feb 01, 05
|
| 16:03 ET |
Serono Reports Strong Full Year 2004 Results
|
|
Jan 24, 05
|
| 01:00 ET |
Serono Announces Completion of Patient Enrollment in Phase III Trial of Serostim(R) (Somatropin [rDNA Origin] for Injection) in HIV-Associated Adipose Redistribution Syndrome (HARS)
|
|
Jan 11, 05
|
| 01:00 ET |
Serono and IVAX to Initiate Phase III Clinical Trial of Mylinax(R) in Multiple Sclerosis
|
|
Jan 10, 05
|
| 01:00 ET |
Serono Announces the Availability of Saizen(r) for Adult Growth Hormone Deficiency (AGHD) in the United States
|
|
Dec 20, 04
|
| 08:01 ET |
Serono Announces FDA Approval of Rebif(R) Titration Pack
|
|
Dec 07, 04
|
| 01:00 ET |
Serono and Micromet to Collaborate in Development and Commercialization of Novel Anti-Cancer Drug
|
|
Nov 15, 04
|
| 01:00 ET |
Serono and Nautilus Biotech Sign Worldwide Agreement to Develop and Commercialize a Next-Generation Growth Hormone
|
|
Nov 10, 04
|
| 01:00 ET |
Serono Announces Appointment of New Chief Financial Officer
|
|
Oct 27, 04
|
| 01:00 ET |
Serono and Paratek Pharmaceuticals in Partnership to Develop a Novel Oral Treatment for Multiple Sclerosis
|
|
Oct 19, 04
|
| 07:30 ET |
Clinical Study Shows Need for Fewer Injections to Prevent Premature Ovulation During the Treatment of Infertility
|
|
Oct 15, 04
|
| 01:00 ET |
FDA Approves Serono's Luveris(R) for Concomitant Use With Gonal-f(R)
|
|
Oct 08, 04
|
| 01:00 ET |
Four Year Data Shows 54% Reduction in Relapse Rate and 76% of MS Patients Remain Free of Disease Progression With Rebif(R)
|
|
Sep 08, 04
|
| 01:00 ET |
ZymoGenetics and Serono Establish Broad Strategic Research, Development and Commercialization Alliance
|
|
Sep 03, 04
|
| 01:00 ET |
Serono Concludes New License Agreement
|
|
Jul 21, 04
|
| 16:38 ET |
Strong Second Quarter With Robust EPS Growth of 28.5%
|
|
| 16:22 ET |
Strong Second Quarter With Robust EPS Growth of 28.5%
|
|
Jun 01, 04
|
| 01:00 ET |
Serono Initiates Phase III Trial of Serostim(R) in HIV-Associated Adipose Redistribution Syndrome
|
|
May 27, 04
|
| 01:00 ET |
Serono Receives FDA Approval for Gonal-F(R) Pen to Treat Infertility
|
|
May 25, 04
|
| 10:32 ET |
Serono Shareholders Approve Resolutions at Annual General Meeting
|
|
| 01:00 ET |
Serono Announces New Share Buy-Back Program for up to CHF 750 Million
|
|
May 04, 04
|
| 01:30 ET |
Serono Launches Zorbtive(TM), First Drug Product for Treatment of Short Bowel Syndrome
|
|
| 01:00 ET |
4SC AG and Serono Sign Worldwide Agreement to Develop and Commercialize Orally Active Compounds for the Treatment of Autoimmune Disorders
|
|
Apr 29, 04
|
| 01:00 ET |
Serono Announces Management Change
|
|
Apr 28, 04
|
| 01:00 ET |
MS Patients Taking High Dose High Frequency Rebif(R) Sustained Reduction in Accumulation of MRI Brain Lesions Over Long Term
|
|
Apr 23, 04
|
| 09:00 ET |
Serono Offers 'Lifeline' To People With Fertility Health Concerns
|
|
Mar 31, 04
|
| 00:01 ET |
Serono's Serostim(R) Improves Lean Body Mass and Physical Performance in Patients With HIV-Associated Wasting
|
|
Mar 29, 04
|
| 09:04 ET |
Serono Receives FDA Approval for New Presentations of Gonal-f(R) to Treat Infertility
|
|
Mar 23, 04
|
| 01:00 ET |
Serono and IVAX Announce Positive Outcome of Pharmacokinetic Trials With Oral Cladribine
|
|
Mar 18, 04
|
| 09:05 ET |
Serono Launches www.Seronofertility.com
|
|
Mar 16, 04
|
| 01:00 ET |
Raptiva(R) (Efalizumab) Receives Approval for Moderate-to-Severe Plaque Psoriasis in Switzerland
|
|
Mar 01, 04
|
| 01:00 ET |
Treatment With Serostim Decreased Visceral Adipose Tissue in Study of Patients With HIV-Associated Adipose Redistribution Syndrome (HARS)
|
|
Feb 25, 04
|
| 01:00 ET |
European Commission Approves GONAL-f(R) Filled-by-Mass Prefilled Pen
|
|
Feb 23, 04
|
| 18:01 ET |
Serono and Swedish Biotech Company InDex Pharmaceuticals Sign Worldwide Agreement to Develop and Commercialize Novel Ulcerative Colitis Treatment
|
|
Feb 12, 04
|
| 01:01 ET |
Low Dose Maintenance Therapy With Recombinant Human Growth Hormone May Sustain Previous Serostim(R) Treatment In HIV Positive Patients With HARS
|
|
Feb 02, 04
|
| 17:00 ET |
Record Year for Serono With Over $2 Billion in Revenues
|
|
Jan 21, 04
|
| 08:58 ET |
Publication of the First Dictionary of Multiple Sclerosis Provides a Valuable Reference Tool for MS Healthcare Professionals and Patients
|
|
Dec 15, 03
|
| 07:00 ET |
Serono, Inc. Launches New Web Site For People with Worsening Multiple Sclerosis and their Physicians
|
|
Dec 02, 03
|
| 01:00 ET |
FDA Approves Serono's Zorbtive(TM) for Use in Patients With Short Bowel Syndrome
|
|
Nov 10, 03
|
| 08:06 ET |
New Survey Highlights Opportunity for People with Multiple Sclerosis to Better Manage and Track Disease Progression
|
|
Oct 30, 03
|
| 01:00 ET |
European Commission Approves Serono's Ovitrelle(R) Solution For Injection In a Pre-Filled Syringe For Treatment of Infertility
|
|
Oct 23, 03
|
| 01:01 ET |
Serono Reports Strong Third Quarter Results
|
|
Oct 08, 03
|
| 07:02 ET |
FDA Approves Serono's Ovidrel(R) Prefilled Syringe for Treatment of Infertility
|
|
Sep 30, 03
|
| 18:53 ET |
FDA Advisory Committee Issues Favorable Recommendation for Efficacy of Luveris(R) in Follicular Development
|
|
Sep 19, 03
|
| 01:31 ET |
New Positive Long-Term Results For Rebif(R) Multiple Sclerosis Treatment Presented at ECTRIMS
|
|
Aug 29, 03
|
| 15:03 ET |
Serono's Serostim(R) Receives Full Approval From FDA For Treatment of Aids Wasting
|
|
Jul 29, 03
|
| 13:00 ET |
The Serono Foundation Awards Three Scientists With Fellowships for Research in Cancer Biology
|
|
Jun 30, 03
|
| 09:30 ET |
Serono Announces Promising Results for Emfilermin, a New Drug for Improving Implantation of Embryos
|
|
Jun 25, 03
|
| 20:02 ET |
Serono Announces Results Of FDA Advisory Committee On Serostim(R) For Use In Patients With Short Bowel Syndrome
|
|
Jun 22, 03
|
| 08:30 ET |
Serono Announces Positive Results For Onercept in Psoriasis and Psoriatic Arthritis In Phase II Trials
|
|
Jun 18, 03
|
| 08:06 ET |
MS Patients Converting From Avonex(R) to Rebif(R) Showed Significant Reduction in Frequency of Relapses and MRI Lesion Activity
|
|
May 30, 03
|
| 08:00 ET |
Final 63-week Evidence Study Data Continue to Show Rebif(R) Significantly More Effective Than Avonex(R) in Reducing Frequency of Relapses and MRI Activity in Relapsing Forms of MS
|
|
May 22, 03
|
| 08:01 ET |
REBIF(R) Labeling Changes reflect Efficacy and Convenience of The FASTEST GROWING MS Treatment in the U.S.
|
|
Apr 24, 03
|
| 01:00 ET |
Serono Announces Good First Quarter Results with Strong Revenue Growth
|
|
Apr 04, 03
|
| 08:01 ET |
Rebif(R) Teams up with The National Multiple Sclerosis Society to Sponsor MS Walks in 225 Cities Nationwide in 2003
|
|
Mar 25, 03
|
| 16:44 ET |
Serono Announces New Senior Management Appointments
|
|
Feb 06, 03
|
| 01:00 ET |
Serono and Genentech Expand Raptiva Agreement to Additional Emerging Markets in Asia
|
|
Feb 03, 03
|
| 01:00 ET |
Serono 2002 Revenues Break Through the $1.5 Billion Mark; Product Sales Up 13.9% to $1.42 Billion
|
|
Dec 18, 02
|
| 17:00 ET |
Serono and Amgen Close Agreement For U.S. Commercialization of Novantrone
|
|
Dec 02, 02
|
| 06:33 ET |
Serono Ceases Purchase of Genset Shares on Nouveau Marche at euro 9.75
|
|
| 01:00 ET |
Serono Ceases Purchase of Genset Shares on Nouveau Marche at euro 9.75
|
|
| 01:00 ET |
Serono to Hold R&D Day for Investors and Analysts Today
|
|
Nov 25, 02
|
| 16:11 ET |
Multiple Sclerosis Patients on Rebif(R) More Likely to Remain Relapse Free Than Patients on Avonex(R) at 48 Weeks
|
|
Nov 08, 02
|
| 05:00 ET |
Results of Serono Tender Offer
|
|
Oct 31, 02
|
| 12:31 ET |
Serono Tender Offers for Genset Expire
|
|
Oct 23, 02
|
| 01:00 ET |
Serono Reports Strong Growth with Third Quarter Sales Up 18%
|
|
Oct 14, 02
|
| 08:33 ET |
Overcoming the Wall of Infertility
|
|
Oct 09, 02
|
| 01:00 ET |
Serono and Cellular Genomics Announce Joint Kinase Discovery Program
|
|
Oct 02, 02
|
| 09:31 ET |
Serono Implements New Serostim(R) Secured Distribution Program
|
|
Sep 30, 02
|
| 09:40 ET |
Serono Announces Positive Results of Serostim(R) Clinical Trial for Treatment of HIV-Related Metabolic Complication
|
|
Sep 23, 02
|
| 02:49 ET |
Serono's Cash Offers for Genset Are Successful
|
|
Jul 24, 02
|
| 01:00 ET |
Serono Reports Second Quarter Underlying Net Income Up 16.1%
|
|
Jul 23, 02
|
| 01:00 ET |
Serono and AstraZeneca Sign Agreement for Development of New Therapy in the Area of Female Infertility
|
|
Jul 11, 02
|
| 01:00 ET |
Serono and Pfizer to Co-Promote Multiple Sclerosis Treatment Rebif(R) in the United States
|
|
Jul 10, 02
|
| 08:31 ET |
Serono to Make CostDoctor Software Available to Fertility Specialists Through Exclusive Distribution Agreement
|
|
Jun 26, 02
|
| 01:00 ET |
Recommended Cash Offer for Genset by Serono - Firm Value of EUR 107.4 Million Based on a Price per Share of EUR 9.75 -
|
|
Jun 06, 02
|
| 01:00 ET |
Cool.click(TM) Needle-Free Device for Growth Hormone Receives Authorization for Marketing in EU
|
|
Jun 04, 02
|
| 16:10 ET |
Serono Announces Settlement with Columbia Laboratories Related to Crinone(R)
|
|
May 28, 02
|
| 01:00 ET |
Serono Announces Outcome of Three Clinical Studies
|
|
May 16, 02
|
| 16:10 ET |
Serono Issues Notification of Counterfeit Serostim(R)
|
|
Apr 19, 02
|
| 16:01 ET |
Serono Sponsors The MS Walk(R) 2002 in Massachusetts and New Hampshire
|
|
Apr 16, 02
|
| 18:29 ET |
EVIDENCE Study Data Confirms That Patients Treated With Rebif(R) Are More Likely to Remain Free of Relapses During 48 Weeks Than Patients on Avonex(R)
|
|
Mar 12, 02
|
| 01:00 ET |
Serono Reintroduces Crinone(R) To US Market
|
|
Mar 11, 02
|
| 01:00 ET |
Serono's Rebif(R) Launched Today in US
|
|
Mar 08, 02
|
| 04:00 ET |
Serono's rebif(R) Receives FDA Approval
|
|
Feb 13, 02
|
| 01:00 ET |
Serono Announces 2001 Underlying Sales Growth of 15%
|
|
Feb 12, 02
|
| 07:02 ET |
Serono Launches SeroJet(TM) Needle-Free Device to Deliver Serostim(R) Human Growth Hormone
|
|
Dec 20, 01
|
| 01:00 ET |
Serono Subscribes to Celera's Genomic Databases
|
|
Nov 28, 01
|
| 16:15 ET |
Serono Believes Crinone(R) Not Yet Ready For Re-Launch
|
|
Oct 30, 01
|
| 01:00 ET |
Serono Reports Rebif(R) Growth of 47% and Announces Early Investment For Rebif(R) in the US
|
|
Oct 08, 01
|
| 01:01 ET |
Serono Confirms Submission of Rebif(R) BLA Amendment to FDA
|
|
Aug 31, 01
|
| 12:40 ET |
Infertility Legislation Signed into Law, Reports RESOLVE of New Jersey
|
|
Aug 19, 01
|
| 13:43 ET |
Serono Now Free to Communicate Full Results of the EVIDENCE Study To Healthcare Professionals
|
|
Jul 24, 01
|
| 01:01 ET |
Serono Announces Record Quarter Results
|
|
Jul 12, 01
|
| 01:01 ET |
Serono Holds First Investor and Analyst R&D Day
|
|
Jun 28, 01
|
| 17:00 ET |
Family Building Act Passes the New Jersey Assembly
|
|
| 06:16 ET |
Results of Four-Year Study of Rebif(R) Published in Neurology
|
|
Jun 24, 01
|
| 07:00 ET |
Family To Share Their Story of Successful Pediatric Growth Hormone Treatment With Needle-Free Delivery System at BIO 2001
|
|
Jun 22, 01
|
| 08:01 ET |
Results of Evidence Study of Rebif(R) Versus Avonex(R) Presented at the World Congress of Neurology in London
|
|
Jun 20, 01
|
| 11:01 ET |
EVIDENCE Study Data to be Presented at the XVII World Congress of Neurology, London on Friday, 22 June 2001
|
|
Jun 14, 01
|
| 08:31 ET |
Infertile Couples Support Bill to Mandate Insurance Coverage for Infertility Treatment
|
|
Jun 13, 01
|
| 14:01 ET |
Major Breakthrough to Improve Detectability of Mad Cow and Other Prion Diseases
|
|
Jun 12, 01
|
| 01:01 ET |
Serono's Extensive MS Research Program to Be Featured in Scientific Journals and Presentations This Month
|
|
May 17, 01
|
| 16:46 ET |
Serono Issues Information on New Counterfeit Serostim(R) LOT
|
|
May 16, 01
|
| 01:00 ET |
Serono and Alkermes to Proceed with Development of Long-Acting Formulation of Recombinant Human Follicle Stimulating Hormone (r-hFSH)
|
|
May 15, 01
|
| 11:01 ET |
Serono Shareholders Approve Resolutions at Annual General Meeting
|
|
May 08, 01
|
| 01:24 ET |
Serono Announces Highly Significant Positive Outcome Of Rebif(R) vs Avonex(R) Study in Multiple Sclerosis
|
|
May 02, 01
|
| 01:00 ET |
Serono Reports Strong Growth in Q1 2001
|
|
Mar 22, 01
|
| 01:00 ET |
Thomas A. Lang Appointed President of Serono, Inc.
|
|
Jan 22, 01
|
| 16:15 ET |
Serono Statement Regarding Counterfeit Serostim(R)
|
|
Oct 23, 00
|
| 07:59 ET |
Serono Recognizes Award Winners From Fertility Nursing Centers of Excellence
|
|
Sep 21, 00
|
| 08:59 ET |
Serono Introduces BABIES(TM) Infertility Benefit Assessment Software During National Infertility Awareness Week (Sept. 17-23)
|
|
Sep 18, 00
|
| 08:59 ET |
Serono Introduces Comprehensive Online Fertility Resource
|
|
Jun 26, 00
|
| 01:00 ET |
Serono Receives FDA Market Clearance For First Needle-Free Device To Deliver Saizen(R) Human Growth Hormone For US Pediatric Market
|
|
Jun 05, 00
|
| 01:01 ET |
Serono Receives New US Marketing Approvals For Gonal-F(R) for Treatment of Infertility in Both Women and Men
|
|
May 22, 00
|
| 08:29 ET |
Serono Announces Latest Information On Use of Vaginal Progesterone Gel For Patients Experiencing Infertility
|
|
May 02, 00
|
| 10:05 ET |
Multiple Sclerosis: New Four-Year Data From Ares-Serono Study Shows Benefits of Early Treatment With High Dose Interferon Beta-1a
|
|
Mar 27, 00
|
| 13:10 ET |
Biotechnology Brings Hope To Infertile Couples
|
|
Mar 23, 00
|
| 11:46 ET |
Long Term Data From Multiple Sclerosis Study With Rebif(R) Confirm Dose- Related Effect and Reinforce Need to Treat MS Patients Early and With Highest Tolerable Dose
|
|
Feb 09, 00
|
| 11:28 ET |
New Web Site Resource Available to Help Parents Understand Growth Disorders in Children
|
|
Jan 28, 00
|
| 08:59 ET |
Ares-Serono and AMRAD Sign an Agreement for Development of 'LIF' In Reproductive Health
|
|
Jan 18, 00
|
| 10:55 ET |
Ares-Serono Sales Break US$1 Billion Mark
|
|
Jan 14, 00
|
| 07:01 ET |
New Potential Approach for the Treatment of Brain Diseases, Leading to Possible Understanding of Creutzfeldt-Jakob Disease and Alzheimer's Disease
|
|
Jan 11, 00
|
| 08:51 ET |
Ares-Serono and Alkermes Sign Agreement for the Development Of a Prolease(R) Formulation of a Therapeutic Protein
|
|
Jan 06, 00
|
| 17:51 ET |
Serono Laboratories, Inc. and Bioject Medical Technologies, Inc. Announce Agreement for Needle-Free Delivery of Saizen(R) Human Growth Hormone
|
|
Nov 19, 99
|
| 10:34 ET |
Serono Laboratories Concurs With Medical Community On New Initiatives To Minimize Multiple Births
|
|
Nov 02, 99
|
| 09:08 ET |
Ares-Serono Posts Excellent Nine Months and Record Third Quarter Results
|
|
Oct 05, 99
|
| 08:29 ET |
Ares-Serono Initiates a Head-To-Head Trial Comparing Rebif(R) And Avonex(R) in Relapsing Remitting Multiple Sclerosis
|
|
Sep 27, 99
|
| 08:33 ET |
Interim Results of Treatment Protocol Positive on Crinone(R)
|
|